Wall Street brokerages expect Axcelis Technologies Inc (NASDAQ:ACLS) to report ($0.03) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Axcelis Technologies’ earnings. The highest EPS estimate is ($0.02) and the lowest is ($0.05). Axcelis Technologies posted earnings of $0.43 per share during the same quarter last year, which suggests a negative year over year growth rate of 107%. The firm is expected to report its next quarterly earnings results after the market closes on Tuesday, August 6th.

On average, analysts expect that Axcelis Technologies will report full-year earnings of $0.35 per share for the current fiscal year, with EPS estimates ranging from $0.24 to $0.52. For the next fiscal year, analysts expect that the company will post earnings of $1.04 per share, with EPS estimates ranging from $0.75 to $1.28. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that cover Axcelis Technologies.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings data on Tuesday, May 7th. The semiconductor company reported $0.18 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.11 by $0.07. The firm had revenue of $91.48 million during the quarter, compared to analyst estimates of $93.05 million. Axcelis Technologies had a net margin of 9.23% and a return on equity of 9.11%. Axcelis Technologies’s quarterly revenue was down 25.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.41 earnings per share.

Several brokerages have weighed in on ACLS. BidaskClub lowered shares of Xperi from a “sell” rating to a “strong sell” rating in a research note on Wednesday, June 19th. Zacks Investment Research cut shares of Glu Mobile from a “buy” rating to a “hold” rating in a research report on Tuesday, April 9th. TheStreet cut shares of ZovioInc . from a “c-” rating to a “d” rating in a research report on Thursday, May 23rd. Benchmark reissued a “buy” rating on shares of Gray Television in a research report on Thursday, May 9th. Finally, Northland Securities set a $13.00 price target on shares of Nabriva Therapeutics and gave the stock a “buy” rating in a research report on Wednesday, May 8th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. Axcelis Technologies currently has an average rating of “Hold” and an average target price of $27.00.

ACLS stock traded down $0.20 during mid-day trading on Thursday, hitting $14.79. 114,400 shares of the company were exchanged, compared to its average volume of 215,977. The company has a quick ratio of 3.73, a current ratio of 5.76 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $491.82 million, a price-to-earnings ratio of 11.29 and a beta of 1.35. The firm’s fifty day simple moving average is $14.97. Axcelis Technologies has a 12-month low of $13.99 and a 12-month high of $25.17.

Several institutional investors and hedge funds have recently modified their holdings of ACLS. BNP Paribas Arbitrage SA lifted its position in shares of Axcelis Technologies by 448.6% during the first quarter. BNP Paribas Arbitrage SA now owns 6,792 shares of the semiconductor company’s stock worth $137,000 after purchasing an additional 5,554 shares in the last quarter. Metropolitan Life Insurance Co. NY lifted its position in shares of Axcelis Technologies by 362.2% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 10,363 shares of the semiconductor company’s stock worth $184,000 after purchasing an additional 8,121 shares in the last quarter. Oregon Public Employees Retirement Fund acquired a new stake in shares of Axcelis Technologies during the fourth quarter worth about $219,000. Texas Permanent School Fund lifted its position in shares of Axcelis Technologies by 4.2% during the fourth quarter. Texas Permanent School Fund now owns 21,210 shares of the semiconductor company’s stock worth $378,000 after purchasing an additional 851 shares in the last quarter. Finally, SG Americas Securities LLC lifted its position in shares of Axcelis Technologies by 62.7% during the first quarter. SG Americas Securities LLC now owns 19,594 shares of the semiconductor company’s stock worth $394,000 after purchasing an additional 7,554 shares in the last quarter. 80.57% of the stock is currently owned by institutional investors and hedge funds.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. The company offers a line of high energy, high current, and medium current implanters for various application requirements. It also provides curing systems and thermal processing systems.

Further Reading: Bollinger Bands

Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.